| Symbol | ANRO |
|---|---|
| Name | ALTO NEUROSCIENCE, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, California, 94041, United States |
| Telephone | +1 650 200-0412 |
| Fax | — |
| — | |
| Website | https://www.altoneuroscience.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Additional info from NASDAQ: |
Alto Neuroscience, Inc. - Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
Read moreNew Form EFFECT - Alto Neuroscience, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 9999999995-26-001257 <b>Size:</b> 1 KB
Read moreNew Form S-3 - Alto Neuroscience, Inc. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001104659-26-041959 <b>Size:</b> 784 KB
Read more(90% Positive) ALTO NEUROSCIENCE, INC. (ANRO) Provides Update on medicines for schizophrenia
Read moreAlto Neuroscience, Inc. - Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
Read moreAlto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
Read moreNew Form ARS - Alto Neuroscience, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0001104659-26-035202 <b>Size:</b> 2 MB
Read moreNew Form DEFA14A - Alto Neuroscience, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0001104659-26-035191 <b>Size:</b> 456 KB
Read moreNew Form DEF 14A - Alto Neuroscience, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0001104659-26-035180 <b>Size:</b> 3 MB
Read more(80% Positive) ALTO NEUROSCIENCE, INC. (ANRO) Announces Enrollment Update for trial Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment
Read more| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Apollo Armband | DEVICE | Approved | Fatigue | COMPLETED | NCT04983342 |
| Apollo Wearable | DEVICE | Approved | Stress Disorders, Post-Traumatic | RECRUITING | NCT05274230 |